Previous research on melanoma showed that SPP1 is a pro-tumoral driver and prognostic factor in melanoma, with bromodomain and extra-terminal domain (BET) inhibitor being a therapeutic agent targeting this protein[67]. Here, SPP1 is linked to melanoma.